Showing results (311-320 of 353) with videos related to

Sort By:
Pageof 36
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 1, 2025
Effect of beta blocker withholding or withdrawal after myocardial infarction without reduced ejection fraction on ischaemic events: a post hoc analysis from the REBOOT trialXavier Rossello, Pedro L Sánchez, Ruth Owen, et al.
Global Health, Science and Practice|September 28, 2019
Unintended Consequences of mHealth Interactive Voice Messages Promoting Contraceptive Use After Menstrual Regulation in Bangladesh: Intimate Partner Violence Results From a Randomized Controlled TrialKate Reiss, Kathryn Andersen, Erin Pearson, et al.
The Lancet. Global Health|December 12, 2025
Enhanced patient counselling and SMS reminder messages to improve access to community-based eye care services in Meru, Kenya: an embedded, pragmatic, individual-level, randomised, controlled, adaptive platform trialLuke N Allen, Min Jung Kim, Michael Gichangi, et al.
European Heart Journal|October 18, 2021
Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBRJavier Escaned, Davide Cao, Usman Baber, et al.
International Journal of Cardiology|April 20, 2023
Biolimus-eluting vs. other limus-eluting stents in NSTE-ACS: A pooled analysis of GLASSY and TWILIGHTAlessandro Spirito, Marco Valgimigli, Davide Cao, et al.
Trials|April 25, 2019
Expert panel process to optimise the design of a randomised controlled trial in chronic rhinosinusitis (the MACRO programme)Helen Blackshaw, Jane Vennik, Carl Philpott, et al.
European Heart Journal|August 30, 2025
Beta-blockers after myocardial infarction: effects according to sex in the REBOOT trialXavier Rossello, Alberto Dominguez-Rodriguez, Roberto Latini, et al.
JAMA Cardiology|May 15, 2021
Sex Differences Among Patients With High Risk Receiving Ticagrelor With or Without Aspirin After Percutaneous Coronary Intervention: A Subgroup Analysis of the TWILIGHT Randomized Clinical TrialBirgit Vogel, Usman Baber, David J Cohen, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|October 17, 2024
Impact of ticagrelor with or without aspirin on total and recurrent bleeding and ischaemic events after percutaneous coronary intervention: a sub-study of the TWILIGHT trialUsman Baber, Davide Cao, Timothy Collier, et al.
JACC. Cardiovascular Interventions|July 9, 2021
Impact of Age on the Safety and Efficacy of Ticagrelor Monotherapy in Patients Undergoing PCIDominick J Angiolillo, Davide Cao, Usman Baber, et al.
Pageof 36